Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM). [electronic resource]
Producer: 20181029Description: 20170172 p. digitalISSN:- 1748-880X
- Administration, Oral
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- metabolism
- Capecitabine -- administration & dosage
- Case-Control Studies
- Chemoradiotherapy -- methods
- Dacarbazine -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Intestinal Neoplasms -- therapy
- Liver -- metabolism
- Male
- Middle Aged
- Neuroendocrine Tumors -- therapy
- Octreotide -- administration & dosage
- Organometallic Compounds -- administration & dosage
- Pancreatic Neoplasms -- therapy
- Prospective Studies
- Radiation-Sensitizing Agents
- Radiometry
- Radiopharmaceuticals -- administration & dosage
- Radiotherapy Dosage
- Spleen -- metabolism
- Stomach Neoplasms -- therapy
- Temozolomide
- Tissue Distribution
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.